Biotechnology - Germany

Filter

Current filters:

Germany

Popular Filters

1 to 25 of 26 results

Merck enters lucrative cancer alliance with Pfizer

Merck enters lucrative cancer alliance with Pfizer

17-11-2014

Germany’s Merck KGaA said today that it has entered into a global agreement with US pharma giant Pfizer…

BiotechnologyGermanyLicensingMarkets & MarketingMerck KGaAMerck SeronoMSB0010718COncologyPfizerUSAXalkori

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

13-11-2014

Cancer diagnostics and personalized medicines specialist ValiRx has agreed to collaborate with Deutsches…

BiologyBiotechnologyGermanyMedicineMolecular geneticsOncologyResearchValiRx

Northwest Bio says DCVax-L hospital exemption program under way in Germany

Northwest Bio says DCVax-L hospital exemption program under way in Germany

15-10-2014

US biotech firm Northwest Biotherapeutics, which is developing DCVax personalized immune therapies for…

BiotechnologyDCVax-LGermanyNorthwest BiotherapeuticsOncologyRegulationResearch

Trials commence on consortium's fully personalized cancer vaccines for glioblastoma

Trials commence on consortium's fully personalized cancer vaccines for glioblastoma

14-10-2014

A consortium funded by the European Union is to advance a new class of fully personalized cancer vaccines…

BioNTechBiotechnologyGermanyimmatics biotechnologiesOncologyResearch

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

07-10-2014

German life sciences major Merck KGaA says its biopharma division Merck Serono has entered into a co-development…

BiotechnologyGermanyLicensingMerck KGaAMerck SeronoOncologyResearch

Merck Serono to partner with Lupin for emerging market exposure

Merck Serono to partner with Lupin for emerging market exposure

17-09-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has entered a strategic partnership with Indian…

Antibiotics and Infectious diseasesBiotechnologyCardio-vascularDiabetesGermanyIndiaLicensingLupinMerck KGaAMerck Serono

Merck Serono pulls plug on tecemotide in Stage III NSCLC

Merck Serono pulls plug on tecemotide in Stage III NSCLC

12-09-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, is to discontinue the clinical development…

BiotechnologyGermanyMerck SeronoOncologyResearch

Merck KGaA's Allergopharma to collaborate with S-TARget on new generation of allergy products

Merck KGaA's Allergopharma to collaborate with S-TARget on new generation of allergy products

02-09-2014

Allergopharma, a division of Germany’s Merck KGaA, and Austrian allergy biotechnology company S-TARget…

AllergopharmaAustriaBiotechnologyGermanyImmunologyInflammatory diseasesMerck KGaAResearch

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

20-08-2014

US biopharmaceutical firm Emergent BioSolutions and Germany’s MorphoSys have entered into an agreement…

BiotechnologyEmergent BioSolutionsES414GermanyLicensingMOR209/ES414MorphoSysOncologyProstate cancerUSA

uniQure acquires cardiology gene therapy firm InoCard

12-08-2014

Netherlands-based human gene therapy firm uniQure says it has acquired Germany’s InoCard GmbH, an innovative,…

BiotechnologyCardio-vascularGermanyInoCardMergers & AcquisitionsNetherlandsuniQure

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

08-08-2014

In its early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG)…

Biogen IdecBiotechnologyGermanyMSNeurologicalPricingRegulationTecfidera

Final funding boost for immatics to complete Phase III study

Final funding boost for immatics to complete Phase III study

16-07-2014

Germany’s privately-held immatics biotechnologies GmbH has received 22 million euros ($29 million)…

BiotechnologyFinancialGermanyimmatics biotechnologiesOncologyRenal cell carcinomaResearchSutent

NicOx launches commercial operations in Germany

30-06-2014

Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

CMO Rentschler expands single-use manufacturing capacities

06-06-2014

German contract manufacturing organization (CMO) Rentschler Biotechnologie has announced the addition…

BiotechnologyGermanyProductionRentschler Biotechnologie

Executive Q&A: Paul Higham, CEO of immatics

Executive Q&A: Paul Higham, CEO of immatics

27-05-2014

In an interview with The Pharma Letter, immatics chief executive Paul Higham discusses the company's…

BiotechnologyCancerGermanyHealth Medical Pharmaimmatics biotechnologiesImmunologyInterviewsMedicineOncologyVaccination

Proteros announces changes in management team

Proteros announces changes in management team

12-05-2014

German biotech company Proteros has announced significant changes in its management team.

BiotechnologyBoardroomGermanyProteros

Gilead’s Sovaldi shows “indication of added benefit for specific patients,” says IQWiG

Gilead’s Sovaldi shows “indication of added benefit for specific patients,” says IQWiG

03-05-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

Anti-viralsBiotechnologyGermanyGilead SciencesPricingSovaldi

Executive Q&A: Epigenomics’ chief executive Dr Thomas Taapken

Executive Q&A: Epigenomics’ chief executive Dr Thomas Taapken

01-04-2014

The Pharma Letter interviewed chief executive Dr Thomas Taapken about Epigenomics’ lead product, increasing…

BiotechnologyEpi proColonEpigenomicsGermanyInterviewsOncology

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

26-03-2014

German pharma and chemical major Merck KGaA has announced the promotion of three distinguished internal…

AllergopharmaBiotechnologyBoardroomGermanyMerck KGaAPharmaceutical

Medigene signs collaboration with Falk Pharma for RhuDex

Medigene signs collaboration with Falk Pharma for RhuDex

19-03-2014

German biotechnology company Medigene has signed an exclusive global license agreement with drugmaker…

BiotechnologyDr Falk PharmaGastro-intestinalsGermanyLicensingMedigeneNephrology and Hepatology

Merck Serono appoints Steven Hildemann as global chief medical officer

Merck Serono appoints Steven Hildemann as global chief medical officer

09-01-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA (MRK: DE), has named Steven Hildemann as global…

BiotechnologyBoardroomGermanyMerck Serono

1 to 25 of 26 results

Back to top